These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8618356)

  • 1. From the Centers for Disease Control and Prevention. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
    JAMA; 1996 May; 275(18):1397. PubMed ID: 8618356
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(14):289-91. PubMed ID: 8598826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use.
    Fishbane S; Cunha BA; Mittal SK; Ruggian J; Shea K; Schoch PE
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):461-2. PubMed ID: 10432156
    [No Abstract]   [Full Text] [Related]  

  • 4. Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.
    McDonald LC; Garza LR; Jarvis WR
    Emerg Infect Dis; 1999; 5(1):143-6. PubMed ID: 10081682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enterococci: acquired antibiotic resistance].
    Alonso T; Pérez JL; Liñares J
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):489-96. PubMed ID: 1489779
    [No Abstract]   [Full Text] [Related]  

  • 6. A change in the molecular epidemiology of vancomycin resistant enterococci in Western Australia.
    Coombs GW; Daley D; Pearson JC; Ingram PR
    Pathology; 2014 Jan; 46(1):73-5. PubMed ID: 24300724
    [No Abstract]   [Full Text] [Related]  

  • 7. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
    van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP
    J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin resistance.
    Hastings JG
    J Med Microbiol; 1997 Jun; 46(6):449-51. PubMed ID: 9379472
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of vancomycin and daptomycin against clinical isolates of Staphylococcus aureus and enterococci from India.
    Jain S; Gaind R; Chugh TD
    Int J Antimicrob Agents; 2013 Jul; 42(1):94-5. PubMed ID: 23611307
    [No Abstract]   [Full Text] [Related]  

  • 10. Vancomycin-resistant enterococci in Brooklyn, New York: a moment in time.
    Landman D; Volkert F; Manikal V; Saurina G; Ruan Y; Oydna E; Parola C; Quale J
    Clin Infect Dis; 1999 Dec; 29(6):1587-8. PubMed ID: 10585828
    [No Abstract]   [Full Text] [Related]  

  • 11. First known outbreak of colonizing vancomycin-resistant enterococci in Quebec.
    Fortin A; Milord F; Guay M; d'Halewyn MA; Vigeant P; Leblanc G
    Can Commun Dis Rep; 1998 Jun; 24(11):85-94. PubMed ID: 9629835
    [No Abstract]   [Full Text] [Related]  

  • 12. Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08.
    Bourdon N; Fines-Guyon M; Thiolet JM; Maugat S; Coignard B; Leclercq R; Cattoir V
    J Antimicrob Chemother; 2011 Apr; 66(4):713-21. PubMed ID: 21393182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant enterococci: an emerging health problem.
    Whittle J; Queenan E
    Pa Med; 1997 Oct; 100(10):30-2. PubMed ID: 9509872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections with vancomycin-resistant enterococci.
    Montecalvo MA; Shay DK; Patel P; Tacsa L; Maloney SA; Jarvis WR; Wormser GP
    Arch Intern Med; 1996 Jul; 156(13):1458-62. PubMed ID: 8678715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant enterococci.
    Moellering RC
    Clin Infect Dis; 1998 May; 26(5):1196-9. PubMed ID: 9597252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).
    Papadimitriou-Olivgeris M; Kolonitsiou F; Zerva L; Lebessi E; Koutsia C; Drougka E; Sarrou S; Giormezis N; Vourli S; Doudoulakakis A; Konsolakis C; Marangos M; Anastassiou ED; Petinaki E; Spiliopoulou I
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):386-8. PubMed ID: 26341703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-resistant Enterococcus.
    Bensoussan R; Weiss K; Laverdiere M
    Scand J Gastroenterol; 1998 Dec; 33(12):1233-8. PubMed ID: 9930384
    [No Abstract]   [Full Text] [Related]  

  • 18. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)].
    Kuwahara K; Hanaki H; Hiramatsu K
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):182-5. PubMed ID: 10088368
    [No Abstract]   [Full Text] [Related]  

  • 20. Should genotypic testing be done on all phenotypically vancomycin- resistant enterococci detected in hospitals?
    Coombs GW; Kay ID; Steven RA; Pearman JW; Bertolatti D; Grubb WB
    J Clin Microbiol; 1999 Apr; 37(4):1229-30. PubMed ID: 10215453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.